|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Pharma's Image Fix: Lessons from the Fieldabout 8 years ago
The Innovation Distinction: Biopharma's Reputational Passabout 8 years ago
Valeant’s Northern Faceabout 8 years ago
More New Drugs and Generics Reshape Pharma Marketsabout 8 years ago
Leadership in All the Right Placesabout 8 years ago
Industry Engine CheckNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5